4/15/2026Sirtex's DOORwaY90 Trial Sets New Benchmark in Unresectable HCC With 1...

4/15/2026Shanghai Minwei's Triple Agonist MWN109 Shows Strong Early Weight-Loss...

4/13/2026BioNTech and DualityBio Report Positive Registrational Phase 2 Results...

4/13/2026Innovent Presents Preclinical Oral Data for Tri-Specific Autoimmune T-...

4/13/2026Oculgen Launches Global Phase II/III Trial of OCUL101 in Wet AMD

4/13/2026CanSino Wins China Approval for Three-Component DTcP Combination Vacci...

4/13/2026AstraZeneca's Imjudo Wins China Approval, Likely for First-Line EGFR/A...

4/13/2026BeOne Secures China Conditional Approval for Imdylltra in Third-Line E...

4/10/2026Xuanzhu Expands Global Oncology Reach With Boston Oncology Licensing D...

4/9/2026Luye Advances Next-Gen Schizophrenia Candidate LY03020 Into Phase II i...

4/9/2026GSK Wins China Approval for Exdensur in Chronic Rhinosinusitis With Na...

4/9/2026NMPA Clears BioGenesis's Recombinant Human Hyaluronidase

4/7/2026Henlius Wins China IND Approval for HLX319, Advancing SC HER2 Breast C...

4/3/2026Hengrui Unveils Promising Phase 1 Data for FIC Dual-Target Psoriasis A...

4/3/2026Earendil Advances AI-Designed TL1A Antibody Into Mid-Stage UC Trial

4/3/2026Abbisko Advances ABSK061 Into US Clinical Development for Achondroplas...

4/1/2026Salubris Unveils Long-Acting Blood Pressure siRNA Data at ACC 2026

4/1/2026Alphamab and CSPC Win Phase III Breast Cancer Success for KN026 Neo-He...

4/1/2026Fosun Pharma Wins China Trial Nod for Teva-Partnered FXB0871

4/1/2026Abbisko Wins EMA Orphan Drug Designation for Irpagratinib in Liver Can...

3/31/2026Huahui Launches World's First Approved Hepatitis D Antibody Drug in Ch...

3/31/2026Connect Biopharma Reports Promising Late-Stage China Results for Eczem...

3/31/2026Braveheart Bio Posts Promising Mid-Stage China Data for HCM Drug Licen...

3/31/2026Innovent Publishes Strong Phase II Mazdutide 9 mg Obesity Data as Chin...

3/31/2026Simcere Highlights Late-Breaking Phase III Success for Rademikibart in...

3/30/2026Dizal Reports Strong First-Line ELCC 2026 Data for ZEGFROVY in Uncommo...

3/30/2026Enhertu Wins First Global Approval in Neoadjuvant HER2-Positive Early ...

3/30/2026BioRay and UCB Win Dual China Dermatology Approvals for Bimzelx

3/30/2026China Approves Claruvis's Retoxin, Marking New Milestone in Recombinan...

3/30/2026Almirall Partners Shanghai Huaota in $340 Million Dermatology Antibody...

Page:1/22 Total number of articles:658: [First][<<] [1] [2] [3] [4] [5] [>>] [End]